Induction and displacement of an α helix in the 6725 SERA peptide analogue confers protection against P. falciparum malaria

Vaccine

Volumn 22, Issue 9-10, 2004, Pages 1281-1289

  Alba, Martha Patricia ^a   Salazar, Luz Mary ^a   Purmova, Jindra ^a   Vanegas, Magnolia ^a   Rodriguez, Raul ^a   Patarroyo, Manuel Elkin ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Malaria; NMR; Peptide; SERA

Indexed keywords

AMINO ACID; MALARIA VACCINE; PARASITE ANTIGEN; PEPTIDE; PEPTIDE 22830; PEPTIDE 23422; PEPTIDE 6275; SERINE REPEAT ANTIGEN; UNCLASSIFIED DRUG; SERINE REPEAT ANTIGEN, PLASMODIUM;

ALPHA HELIX; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; AOTUS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROCYTE; HUMORAL IMMUNITY; IMMUNOGENICITY; MALARIA FALCIPARUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PEPTIDE ANALYSIS; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; AMINO ACID SEQUENCE; ANIMAL; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN CONFORMATION; TEMPERATURE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; AOTUS TRIVIRGATUS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MAGNETIC RESONANCE SPECTROSCOPY; MALARIA VACCINES; MALARIA, FALCIPARUM; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN CONFORMATION; TEMPERATURE;

EID: 1542301023     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.08.046     Document Type: Article

References (36)

1. Breman J.G. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 64:2001;1-11.
2. Richie T.L., Saul A. Progress and challenges for malaria vaccines. Nature. 415:2002;694-701.
3. Bzik D.J., Horii T., Inselburg J. Aminoacid sequence of the serine repeat antigen (SERA) of Plasmodium falciparum determined from cloned cDNA. Mol. Biochem. Parasitol. 30:1988;279-288.
4. Perrin L.H., Merkli B., Loche M., Chizzolini C., Smart J., Richle R. Antimalarial immunity in Saimiri monkeys immunization with surface components of asexual blood stages. J. Exp. Med. 160:1984;441-451.
5. Delplace P., Fortier B., Tronchin C., Dubremetz J.F., Vernes A. Localization, biosynthesis, processing and isolation of major 126. kDa antigen of the parasitophorous vacuole of Plasmodium falciparum Mol. Biochem. Parasitol. 23:1987;193-201.
6. Chulay J.D., Lyon J.A., Haynes D.J., Mierovics A.I., Atkinson C.T., Aikawa M. Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum. J. Immun. 139:1987;2768-2774.
7. Knapp B., Hundt E., Nau U., Küpper H.A. Molecular cloning genomic structure and localization in a blood stage antigen of Plasmodium falciparum characterized by a serine stretch. Mol. Biochem. Parasitol. 32:1989;73-84.
8. Fox B.A., Bzik D.J. Analysis of stage-specific transcripts of the Plasmodium falciparum SERA gene and transcription from the SERA locus. Mol. Biochem. Parasitol. 68:1994;133-144.
9. Lyon J.A., Thomas A.W., Hall T., Chulay J.D. Specifities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes. Mol. Biochem. Parasitol. 36:1989;77-86.
10. Perkins M.E., Ziefer A. Preferential binding of Plasmodium falciparum SERA and rhoptry proteins to erythrocyte membrane inner leaflet phospholipids. Infect. Immun. 62:1994;1207-1212.
11. Puentes A., Garcia J., Vera R., Lopez R., Urquiza M., Vanegas M.et al. Serine repeat antigen peptides which bind specifically to red blood cells. Parasitol. Int. 49:2000;105-117.
12. Ocampo M., Urquiza M., Vera R., Guzman F., Rodríguez L.E., Suarez J.et al. Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion. J. Peptide Res. 55:2000;216-223.
13. Espejo F., Cubillos M., Salazar L.M., Guzman F., Urquiza M., Ocampo M.et al. Structure, immunogenicity, and protectivity relationship for the 1585 malarial peptide and its substitution analogues. Angew. Chem. 40(24):2001;4654-4657.
14. 1H NMR structures of the Plasmodium falciparum 1758 erythrocyte binding peptide analogues and protection against malaria Life Sci. 71:2002;2773-2785.
15. Salazar L.M., Alba M.P., Torres M.H., Pinto M., Cortes X., Torres L.et al. Protection against experimental malaria associated with AMA-1 peptide analogue structures. FEBS Lett. 527:2002;95-100.
16. 1H NMR J. Struct. Biol. 141:2003;115-121.
17. Houghten R.A. General method for the rapid solid phase synthesis of large numbers of peptides: specificity of antigen antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. U.S.A. 82:1985;5131-5135.
18. Rodríguez R., Moreno A., Guzmán F., Calvo M., Patarroyo M.E. Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 43:1990;339-354.
19. Pico de Coaña Y, Guerrero E, Barrero C, Rodriguez J, Rodriguez R, Patarroyo ME. A highly infective Plasmodium vivax strain adapted to Aotus monkeys. Quantitative hematological and molecular determinations useful for P. vivax malaria vaccine development. Vaccine, in press.
20. Lambros C., Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocyte stages in culture. J. Parasitol. 65:1979;418-420.
21. Blake M.S., Johnston H., Russell-Jones G.J., Gotschlich E.C. A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal. Biochem. 136(1):1984;175-179.
22. Roccatano D., Colombo G., Fiorone M., Mark A.E. Mechanism by which 2,2,2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: a molecular dynamics study. Proc. Natl. Acad. Sci. U.S.A. 99:2002;12179-12184.
23. 1H NMR spectra of proteins via double quantum filtering Biochem. Biophys. Res. Commun. 117:1983;479-485.
24. Bax A., Davis D.G. MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Resonance. 65:1985;355-360.
25. Jeener J., Meier B.H., Backman P., Ernst R.R. Investigation of enhance processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 71:1979;4546-4553.
26. Wüthrich K. NMR of proteins and nucleic acids. New York (NY): Wiley; 1986.
27. Ch H., Merutka G., Waltho J., Wright P.E., Dyson H.J. Peptide models of protein folding initiation sites. 2. The G-H turn region of myoglobin acts as a helix stop signal. Biochemistry. 32:1993;6348-6351.
28. Kabsch W., Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 22:1983;2577-2637.
29. Cubillos M., Espejo F., Purmova J., Martinez J.C., Patarroyo M.E. Alpha helix shortening in 1522 MSP-1 conserved peptide analogs is associated with immunogenicity and protection against P. falciparum malaria. Proteins. 50:2003;400-409.
30. Cubillos M., Salazar L.M., Torres L., Patarroyo M.E. Protection against experimental P. falciparum malaria is associated with short AMA-1 peptide analogue α-helical structures. Biochimie. 84:2003;1181-1188.
31. Purmova J., Salazar L.M., Espejo F., Torres M.H., Cubillos M.et al. NMR structure of Plasmodium falciparum malaria peptide correlates with protective immunity. Biochim. Biophys. Acta. 1571:2002;27-33.
32. Cifuentes G., Patarroyo M.E., Urquiza M., Ramirez L.E., Reyes C., Rodriguez R. Distorting malaria peptide backbone structure to enable fitting into MHC Class II molecules renders modified peptides immunogenic and protective. J. Med. Chem. 46:2003;2250-2253.
33. Sloan-Lancaster J., Allen P.M. Altered peptide ligand induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1996;1-27.
34. Lyons D.S., Lieberman S.A., Hampl J., Boniface J.J., Chien Y-H., Bergr L.J. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 5:1996;53-61.
35. Kersh G., Miley M., Nelson C.A., Grakoui A., Horvarth S., Donermeyer D. et al. Structural and functional consequences of altering a peptide MHC anchor residue. J. Immunol. 166:2001;3345-3354.
36. Baker B.M., Gagnon S.J., Biddison W.E., Wiley D.C. Conversion of a T Cell antagonist into agonist by repairing a defect in the TCR-peptide-MHC interface: implications for TCR signalling. Immunity. 13:2000;475-484.